| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681704 | Clinical Neurology and Neurosurgery | 2018 | 23 Pages |
Abstract
These results are consistent with and corroborate our previous findings demonstrating that targeting these two parallel pathways with c-Met and EGFR inhibitor therapy provides substantial anti-tumor activity in glioblastoma models.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
C. Rory Goodwin, Prakash Rath, Olutobi Oyinlade, Hernando Lopez, Salman Mughal, Shuli Xia, Yunqing Li, Harsharan Kaur, Xin Zhou, A. Karim Ahmed, Sandra Ho, Alessandro Olivi, Bachchu Lal,